Skip to main content

Free Will and Indeterminism

A fairly lengthy quote here from Robert Kane, a distinguished philosopher in the incompatibilist/voluntarist camp, and in the photo you see.

 "[I]ndeterminism does not have to be involved in all acts done 'of our own free wills' for which we are ultimately responsible, as argued earlier. Not all such acts have to be undetermined, but only those by which we made ourselves into the kinds of persons we are, namely 'self-forming actions' or SFAs. Now I believe these undetermined self-forming actions or SFAs occur at those difficult times of life when we are torn between competing visions of what we should do or become. Perhaps we are torn between doing the moral thing or acting from ambition, or between powerful present desires and long term goals, or we are faced with a difficult tasks for which we have aversions. In all such cases, we are faced with competing motivations and have to make an effort to overcome temptation to do something else we also strongly want. There is tension and uncertainty in our minds about what to do at such times, I suggest, that is reflected in appropriate regions of our brains by movement away from thermodynamic equilibrium--in short, a kind of 'stirring up of chaos' in the brain that makes it sensitive to micro-indeterminacies at the neuronal level. The uncertainty and inner tension we feel at such soul-searching moments of self-formation is thus reflected in the indeterminacy of our neural processes themselves. What is experienced internally as uncertainty then corresponds physically to the opening of a window of opportunity that temporarily screens off complete determination by influences of the past. (By contrast, when we act from predominant motives or settled dispositions, the uncertainty or indeterminacy is muted....)"


Popular posts from this blog

A Story About Coleridge

This is a quote from a memoir by Dorothy Wordsworth, reflecting on a trip she took with two famous poets, her brother, William Wordsworth, and their similarly gifted companion, Samuel Taylor Coleridge.

We sat upon a bench, placed for the sake of one of these views, whence we looked down upon the waterfall, and over the open country ... A lady and gentleman, more expeditious tourists than ourselves, came to the spot; they left us at the seat, and we found them again at another station above the Falls. Coleridge, who is always good-natured enough to enter into conversation with anybody whom he meets in his way, began to talk with the gentleman, who observed that it was a majestic waterfall. Coleridge was delighted with the accuracy of the epithet, particularly as he had been settling in his own mind the precise meaning of the words grand, majestic, sublime, etc., and had discussed the subject with William at some length the day before. “Yes, sir,” says Coleridge, “it is a majestic wate…

England as a Raft?

In a lecture delivered in 1880, William James asked rhetorically, "Would England ... be the drifting raft she is now in European affairs if a Frederic the Great had inherited her throne instead of a Victoria, and if Messrs Bentham, Mill, Cobden, and Bright had all been born in Prussia?"

Beneath that, in a collection of such lectures later published under James' direction, was placed the footnote, "The reader will remember when this was written."

The suggestion of the bit about Bentham, Mill, etc. is that the utilitarians as a school helped render England ineffective as a European power, a drifting raft.

The footnote was added in 1897. So either James is suggesting that the baleful influence of Bentham, Mill etc wore off in the meantime or that he had over-estimated it.

Let's unpack this a bit.  What was happening in the period before 1880 that made England seem a drifting raft in European affairs, to a friendly though foreign observer (to the older brother…

Cancer Breakthrough

Hopeful news in recent days about an old and dear desideratum: a cure for cancer. Or at least for a cancer, and a nasty one at that.

The news comes about because investors in GlaxoSmithKline are greedy for profits, and has already inspired a bit of deregulation to boot. 

The FDA has paved the road for a speedy review of a new BCMA drug for multiple myeloma, essentially cancer of the bone marrow. This means that the US govt has removed some of the hurdles that would otherwise (by decision of the same govt) face a company trying to proceed with these trials expeditiously. 

This has been done because the Phase I clinical trial results have been very promising. The report I've seen indicates that details of these results will be shared with the world on Dec. 11 at the annual meeting of the American Society of Hematology. 

The European Medicines Agency has also given priority treatment to the drug in question. 

GSK's website identifies the drug at issue as "GSK2857916," althou…